‘Toxic' claim against supplement giant
Dominic Noonan-O'Keeffe began taking Blackmores supplements in May 2023 to support his health, ahead of the birth of his first child.
Unaware the magnesium product contained potentially 'toxic' levels of vitamin B6, he claims he soon developed severe symptoms – including fatigue, headaches, muscle spasms, heart palpitations, and loss of sensation, according to Polaris lawyers.
Doctors later diagnosed him with neuropathy linked to excessive B6 intake.
Despite stopping in early 2024, Mr Noonan-O'Keeffe claims he continues to suffer daily from nerve pain and other symptoms.
Polaris Lawyers – who are representing Mr Noonan-O'Keeffe, the lead plaintiff in the potential class-action – allege they later discovered the magnesium product contained about 29 times the recommended daily intake of vitamin B6. Mr Noonan-O'Keeffe claims he suffered lasting health impacts after taking Blackmores Magnesium+. Supplied Credit: Supplied
Polaris Lawyers is now investigating a proposed class action against Blackmores for the excessive B6 levels in their vitamin supplements.
'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake,' Polaris Lawyers Founder and Principal Nick Mann said.
'What happened to Dominic is tragic, but he is not alone – we are aware of reports that excessive levels of B6 in over-the-counter supplements may have caused lasting injuries to hundreds of Australians.
'Polaris Lawyers is currently investigating a class action on behalf of anyone who has suffered injuries as a result of excessive levels of B6 as a result of taking Blackmores vitamin supplements.' Blackmores is one of the country's biggest supplement providers. Supplied Credit: Supplied
In an interim decision report released in June, the TGA acknowledged no clear consensus on a safe vitamin B6 level that fully prevents peripheral neuropathy.
The decision proposed rescheduling products containing over 50mg per day as 'Pharmacist Only Medicines.'
A Blackmores spokesperson said they were aware of the TGA's proposed changes.
'At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' the spokesperson said.
'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements.
'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Advertiser
3 hours ago
- The Advertiser
Australia called to lift on global health as US yields
Australia must come to the party with more money to combat climate-related health issues, antimicrobial resistance and future pandemics. That's the bottom line of research that indicates the well-off nation is not pulling enough weight on the world stage to understand, anticipate and respond to emerging international health threats. The Australian government spent just under $630 billion on health between 2017 and 2023, according to a report commissioned by the Australian Global Health Alliance. About $35 billion was directed to health and medical research but just $2 billion was specifically set aside for global research. The country must increase and realign its funding to address and anticipate global health challenges more effectively, the report said. "Despite commendable efforts, Australia's investment in global health research lags behind its international peers," it said. "Key areas such as the impact of climate change on health, antimicrobial resistance, and pandemic preparedness are notably underfunded." Alliance executive director Selina Namchee Lo said the global scientific community was successful in rapidly delivering vaccines and treatments during the COVID-19 pandemic. But where it fell short was equity, with some of the hardest-hit countries missing out. "What we're saying is equity is not optional for global health," Dr Lo told AAP. Another report, also commissioned by the alliance with Pacific Friends of Global Health, detailed the impact of two Australian-backed global public private partnerships in the Indo-Pacific. Australia has collectively poured more than $2.5 billion into The Global Fund and Gavi since 2000, helping to immunise more than 100 million children and save lives in the region. But the country's level of foreign aid has been been in "significant decline" since 2012, stagnating at $US3 billion annually over the past seven years. The multilateral aid landscape is "under pressure" after the US and UK reduced their commitments, the report said. It comes after US President Donald Trump's administration dismantled the US Agency for International Development, cutting funding to its aid programs worldwide. Dr Lo, who has nearly three decades experience in global and international health, said the abrupt exit of USAID left communities "in the lurch". "It's never good to have one group, whether it's a philanthropist or a country, be a monopoly," she said. "Because when they pull out, this is what happens." The Indo-Pacific still accounts for 25 per cent of global infections, with 6.7 million people in the region living with HIV and malaria rampant in Papua New Guinea. Pacific Friends of Global Health chair Brendan Crabb wants Australia to take up the mantle. "As the US administration dramatically steps back from global health leadership, Australia has a critical opportunity to convene and partner with Asia Pacific countries to advance the health priorities of the region," the Burnet Institute chief executive said. Australia must come to the party with more money to combat climate-related health issues, antimicrobial resistance and future pandemics. That's the bottom line of research that indicates the well-off nation is not pulling enough weight on the world stage to understand, anticipate and respond to emerging international health threats. The Australian government spent just under $630 billion on health between 2017 and 2023, according to a report commissioned by the Australian Global Health Alliance. About $35 billion was directed to health and medical research but just $2 billion was specifically set aside for global research. The country must increase and realign its funding to address and anticipate global health challenges more effectively, the report said. "Despite commendable efforts, Australia's investment in global health research lags behind its international peers," it said. "Key areas such as the impact of climate change on health, antimicrobial resistance, and pandemic preparedness are notably underfunded." Alliance executive director Selina Namchee Lo said the global scientific community was successful in rapidly delivering vaccines and treatments during the COVID-19 pandemic. But where it fell short was equity, with some of the hardest-hit countries missing out. "What we're saying is equity is not optional for global health," Dr Lo told AAP. Another report, also commissioned by the alliance with Pacific Friends of Global Health, detailed the impact of two Australian-backed global public private partnerships in the Indo-Pacific. Australia has collectively poured more than $2.5 billion into The Global Fund and Gavi since 2000, helping to immunise more than 100 million children and save lives in the region. But the country's level of foreign aid has been been in "significant decline" since 2012, stagnating at $US3 billion annually over the past seven years. The multilateral aid landscape is "under pressure" after the US and UK reduced their commitments, the report said. It comes after US President Donald Trump's administration dismantled the US Agency for International Development, cutting funding to its aid programs worldwide. Dr Lo, who has nearly three decades experience in global and international health, said the abrupt exit of USAID left communities "in the lurch". "It's never good to have one group, whether it's a philanthropist or a country, be a monopoly," she said. "Because when they pull out, this is what happens." The Indo-Pacific still accounts for 25 per cent of global infections, with 6.7 million people in the region living with HIV and malaria rampant in Papua New Guinea. Pacific Friends of Global Health chair Brendan Crabb wants Australia to take up the mantle. "As the US administration dramatically steps back from global health leadership, Australia has a critical opportunity to convene and partner with Asia Pacific countries to advance the health priorities of the region," the Burnet Institute chief executive said. Australia must come to the party with more money to combat climate-related health issues, antimicrobial resistance and future pandemics. That's the bottom line of research that indicates the well-off nation is not pulling enough weight on the world stage to understand, anticipate and respond to emerging international health threats. The Australian government spent just under $630 billion on health between 2017 and 2023, according to a report commissioned by the Australian Global Health Alliance. About $35 billion was directed to health and medical research but just $2 billion was specifically set aside for global research. The country must increase and realign its funding to address and anticipate global health challenges more effectively, the report said. "Despite commendable efforts, Australia's investment in global health research lags behind its international peers," it said. "Key areas such as the impact of climate change on health, antimicrobial resistance, and pandemic preparedness are notably underfunded." Alliance executive director Selina Namchee Lo said the global scientific community was successful in rapidly delivering vaccines and treatments during the COVID-19 pandemic. But where it fell short was equity, with some of the hardest-hit countries missing out. "What we're saying is equity is not optional for global health," Dr Lo told AAP. Another report, also commissioned by the alliance with Pacific Friends of Global Health, detailed the impact of two Australian-backed global public private partnerships in the Indo-Pacific. Australia has collectively poured more than $2.5 billion into The Global Fund and Gavi since 2000, helping to immunise more than 100 million children and save lives in the region. But the country's level of foreign aid has been been in "significant decline" since 2012, stagnating at $US3 billion annually over the past seven years. The multilateral aid landscape is "under pressure" after the US and UK reduced their commitments, the report said. It comes after US President Donald Trump's administration dismantled the US Agency for International Development, cutting funding to its aid programs worldwide. Dr Lo, who has nearly three decades experience in global and international health, said the abrupt exit of USAID left communities "in the lurch". "It's never good to have one group, whether it's a philanthropist or a country, be a monopoly," she said. "Because when they pull out, this is what happens." The Indo-Pacific still accounts for 25 per cent of global infections, with 6.7 million people in the region living with HIV and malaria rampant in Papua New Guinea. Pacific Friends of Global Health chair Brendan Crabb wants Australia to take up the mantle. "As the US administration dramatically steps back from global health leadership, Australia has a critical opportunity to convene and partner with Asia Pacific countries to advance the health priorities of the region," the Burnet Institute chief executive said. Australia must come to the party with more money to combat climate-related health issues, antimicrobial resistance and future pandemics. That's the bottom line of research that indicates the well-off nation is not pulling enough weight on the world stage to understand, anticipate and respond to emerging international health threats. The Australian government spent just under $630 billion on health between 2017 and 2023, according to a report commissioned by the Australian Global Health Alliance. About $35 billion was directed to health and medical research but just $2 billion was specifically set aside for global research. The country must increase and realign its funding to address and anticipate global health challenges more effectively, the report said. "Despite commendable efforts, Australia's investment in global health research lags behind its international peers," it said. "Key areas such as the impact of climate change on health, antimicrobial resistance, and pandemic preparedness are notably underfunded." Alliance executive director Selina Namchee Lo said the global scientific community was successful in rapidly delivering vaccines and treatments during the COVID-19 pandemic. But where it fell short was equity, with some of the hardest-hit countries missing out. "What we're saying is equity is not optional for global health," Dr Lo told AAP. Another report, also commissioned by the alliance with Pacific Friends of Global Health, detailed the impact of two Australian-backed global public private partnerships in the Indo-Pacific. Australia has collectively poured more than $2.5 billion into The Global Fund and Gavi since 2000, helping to immunise more than 100 million children and save lives in the region. But the country's level of foreign aid has been been in "significant decline" since 2012, stagnating at $US3 billion annually over the past seven years. The multilateral aid landscape is "under pressure" after the US and UK reduced their commitments, the report said. It comes after US President Donald Trump's administration dismantled the US Agency for International Development, cutting funding to its aid programs worldwide. Dr Lo, who has nearly three decades experience in global and international health, said the abrupt exit of USAID left communities "in the lurch". "It's never good to have one group, whether it's a philanthropist or a country, be a monopoly," she said. "Because when they pull out, this is what happens." The Indo-Pacific still accounts for 25 per cent of global infections, with 6.7 million people in the region living with HIV and malaria rampant in Papua New Guinea. Pacific Friends of Global Health chair Brendan Crabb wants Australia to take up the mantle. "As the US administration dramatically steps back from global health leadership, Australia has a critical opportunity to convene and partner with Asia Pacific countries to advance the health priorities of the region," the Burnet Institute chief executive said.
Sky News AU
3 hours ago
- Sky News AU
'Not up for negotiation': Aussies expected to save $200m a year from major cap on PBS-listed scripts despite tariff threats to industry
Millions of Australians are expected to save $200m in vital medication fees as a landmark bill caps the price of Pharmaceutical Benefits Scheme (PBS) prescriptions at just $25, down from $31.60. The bill is set to take effect from January 1, as the Labor government takes the first steps to legislate the bill and Prime Minister Anthony Albanese vows to keep his election pledge on cost of living relief. The changes mean the cost of medicines on the PBS could be significantly reduced by over 20 per cent. Minister for Health, Mark Butler said five million Australians will feel the relief in their pockets. The cost of medicine for pension and concession card holders will remain frozen at $7.70 until the end of 2029. The bill which was announced by Labor during the May election campaign is expected to cost the budget $690m over four years. Mr Albanese said it built on a pledge for cost of living relief. 'This is another example of cost of living relief that helps every Australian,' he said. 'The size of your bank balance shouldn't determine the quality of your healthcare. My government will continue to deliver cost of living relief for all Australians.' Mr Butler added general patients' medicines haven't been this cheap since 2004. 'The Albanese Government has been focused on delivering cheaper medicines for Australians," he said. 'Cheaper medicines are good for the hip pocket and good for your health." The Assistant Health Minister, Emma McBride said the bill was set to pass despite US President Donald Trump's 200 per cent tariff threat on pharmaceutical imports. The US is Australia's biggest pharmaceutical export market and if the tariff is implemented it could cost the Australian economy up to $2.8 billion and force pharmas' to hike up their prices. However, Ms McBride said the PBS is not up for negotiation and "it is not a bargaining chip". "Labor introduced the Pharmaceutical Benefits Scheme to make sure that essential medicines were available to all Australians, and with this introduction of legislation to enact our election commitment, it will mean a cap on $25, which will save Australians about $200 million a year, 5.1 million Australians estimated to benefit," she said.
Sky News AU
4 hours ago
- Sky News AU
Labor's move to reduce PBS prescription cost will save Australians $200 million a year
The Albanese government is set to reduce PBS prescription prices to $25. Health Minister Mark Butler said the move will save five million Australian patients $200 million a year.
